2021 annual financial data
Tempest Therapeutics 2021 Operating cash flow
Direct answer
Operating cash flow was -25,957,000 USD.
Operating income was -26,986,000 USD and net income was -28,302,000 USD.
Operating cash flow was -25,957,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,986,000 USD
- Net income
- -28,302,000 USD
- Operating cash flow
- -25,957,000 USD